Concepedia

B. Kenneth Koe

BK

53

Publications

5.4K

Citations

27

H-Index

1951

Active since

Affiliations

Pfizer (United States)(Current)

California Institute of Technology

B. Kenneth Koe is an author at Pfizer (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1951–1994

53

Publications

53

p-CHLOROPHENYLALANINE: A SPECIFIC DEPLETOR OF BRAIN SEROTONIN

B. Kenneth Koe, Albert Weissman · Journal of Pharmacology and Experimental Therapeutics · 1966 · 1.8K citations

Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.

B. Kenneth Koe · Journal of Pharmacology and Experimental Therapeutics · 1976 · 500 citations

ANTIAMPHETAMINE EFFECTS FOLLOWING INHIBITION OF TYROSINE HYDROXYLASE

Albert Weissman, B. Kenneth Koe, S. S. Tenen · Journal of Pharmacology and Experimental Therapeutics · 1966 · 452 citations

4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants

Reinhard Sarges, Harry Howard, Ronald G. Browne et al. · Journal of Medicinal Chemistry · 1990 · 407 citations · Full text

Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.

B. Kenneth Koe, Arthur D. Weissman, W. M. WELCH et al. · Journal of Pharmacology and Experimental Therapeutics · 1983 · 257 citations · Full text

Rows per page

1–5 of 53